Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1359757

registered interest
date	15/10/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	HIV Infection: Disease Control
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what funding is being made available to help eradicate HIV transmission in England by 2030.
tabling member constituency	Luton North
tabling member printed	Sarah Owen
uin	57386
answer	answer is ministerial correction date of answer 25/10/2021 answer text <p>HIV testing and prevention is funded by local government through the ringfenced Public Health Grant. We have provided £3.324 billion to local authorities in England to fund public health services in 2021/22, including sexual health and HIV services. We have invested in the successful deployment of pre-exposure prophylaxis (PrEP) in England and the Public Health Grant in 2021/22 includes £23.4 million to cover local authorities’ costs of routine commissioning of PrEP.</p><p>Funding for HIV treatment and care services is provided by NHS England and NHS Improvement through specialised commissioning. Decisions on future funding for are being taken as part of the forthcoming Spending Review. It is for individual local authorities to decide their spending priorities based on an assessment of local need, including the need for HIV prevention services Funding for PrEP in 2021/22 has been allocated using a specific formula which recognises that the level of risk of acquiring HIV is distributed differently to the approach taken for the Public Health Grant.</p> answering member constituency Erewash answering member printed Maggie Throup grouped question UIN 56275 56294 56420 57387 question first answered 25/10/2021 16:53:44 answering member 4447 label Biography information for Maggie Throup
tabling member	4777 label Biography information for Sarah Owen

1202047

registered interest
date	09/06/2020
answering body	Department for International Development
answering dept id	20
answering dept short name	International Development
answering dept sort name	International Development
hansard heading	Yemen: Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for International Development, what steps he is taking to ensure that some of the Government’s £160 million humanitarian aid package for Yemen is used to stop the spread of covid-19 in communities on both sides of the conflict; and what assessment he has made of the potential merits of using UN-backed Yemeni-led frameworks established by (a) the International Initiative on COVID-19 in Yemen and (b) other private sector organisations to deliver aid to both sides.
tabling member constituency	East Lothian
tabling member printed	Kenny MacAskill
uin	57386
answer	answer is ministerial correction date of answer 15/06/2020 answer text <p>The UK announced our new pledge of £160 million in humanitarian funding for Yemen in the 2020/21 financial year at the Yemen Pledging Conference on 2 June.</p><p>As part of this commitment, the UK will support the UN’s plans to tackle the spread of COVID-19 in Yemen and expects to provide over 700,000 medical consultations, train 12,000 healthcare workers to work safely in a COVID-19 environment and provide a much-needed boost to nearly 4,000 health centres to continue providing existing health services.</p><p>In addition, the UK is also supporting the Yemeni Private Sector Cluster, which in April sourced a vital shipment of COVID-19 related supplies and equipment for Yemen.</p> answering member constituency Braintree answering member printed James Cleverly grouped question UIN 57387 question first answered 15/06/2020 15:30:34 answering member 4366 label Biography information for James Cleverly
tabling member	4772 label Biography information for Kenny MacAskill

657931

registered interest
date	13/12/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the potential effect of the £100,000 quality adjusted life year threshold for evaluating Highly Specialised Technologies on the access and update of new medicines for patients with very rare and complex diseases.
tabling member constituency	Cambridge
tabling member printed	Daniel Zeichner
uin	57386
answer	answer is ministerial correction date of answer 20/12/2016 answer text <p>We are committed to ensuring that patients with rare and ultra-rare diseases in England are able to access effective treatments.</p><p> </p><p>The National Institute for Health and Care Excellence (NICE) has advised that the proposed arrangements are intended to provide clarity about the level of cost effectiveness below which funding will be made available, automatically and without delay, for highly specialised technologies that receive positive recommendations from NICE.</p><p> </p><p>Subject to the outcome of the current consultation exercise, those products that have a value proposition of above £100,000 per quality-adjusted life year will be provided with a further opportunity to be considered for use in the National Health Service, through NHS England’s annual process for deciding which new treatments and services will be routinely commissioned.</p><p> </p><p>Furthermore, the proposed changes are intended to clarify NICE’s existing responsibility to determine the period within which funding for recommended products needs to be made available by commissioners of services. This clarity should allow companies and commissioners to work on commercial arrangements in advance of and in parallel with the development of NICE technology appraisal and highly specialised technology guidance. In circumstances where this may not be possible, specific requests from commissioners to vary the timescale for the funding requirement will be considered by NICE.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood grouped question UIN 57384 57385 57387 question first answered 20/12/2016 15:55:01 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	4382 label Biography information for Daniel Zeichner